Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis

Overview

Journal Nutrients

Date 2018 Feb 7

PMID 29401710

Citations 17

Authors

Machi Atarashi

Takeshi Izawa

Rena Miyagi

Shoko Ohji

Ai Hashimoto

Mitsuru Kuwamura

Jyoji Yamate

Affiliations

Soon will be listed here.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now the most common liver disease in the world. NAFLD can progress to nonalcoholic steatohepatitis (NASH), cirrhosis and eventually hepatocellular carcinoma. Acquired hepatic iron overload is seen in a number of patients with NAFLD; however, its significance in the pathology of NAFLD is still debated. Here, we investigated the role of dietary iron supplementation in experimental steatohepatitis in rats. Rats were fed a control, high-fat (HF), high-fat high-iron (HFHI) and high-iron (HI) diet for 30 weeks. Blood biochemical, histopathological and gut microbiota analyses were performed. Rats in HF and HFHI groups showed an ALT-dominant elevation of serum transaminases, hepatic steatosis, hepatic inflammation, and upregulation of proinflammatory cytokines. The number of large inflammatory foci, corresponding to lobular inflammation in NASH patients, was significantly higher in HFHI than in HF group; within the lesion, macrophages with intense iron staining were observed. Hepatic expression of TNFα was higher in HFHI than that in HF group. There was no significant change in hepatic oxidative stress, gut microbiota or serum endotoxin levels between HF and HFHI groups. These results suggested that dietary iron supplementation enhances experimental steatohepatitis induced by long-term high-fat diet feeding in rats. Iron-laden macrophages can play an important role in the enhancement of hepatic inflammation.

Citing Articles

Unraveling the Role of the Human Gut Microbiome in Health and Diseases.

Khalil M, Di Ciaula A, Mahdi L, Jaber N, Di Palo D, Graziani A Microorganisms. 2024; 12(11).

PMID: 39597722 PMC: 11596745. DOI: 10.3390/microorganisms12112333.

Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Saigo Y, Uno K, Ishigure T, Odake T, Ohta T In Vivo. 2024; 38(3):990-999.

PMID: 38688597 PMC: 11059886. DOI: 10.21873/invivo.13532.

Absence of Increased Susceptibility to Acetaminophen-Induced Liver Injury in a Diet-Induced NAFLD Mouse Model.

Izawa T, Travlos G, Cortes R, Clayton N, Sills R, Pandiri A Toxicol Pathol. 2023; 51(3):112-125.

PMID: 37158481 PMC: 10523943. DOI: 10.1177/01926233231171101.

Dietary iron overload enhances Western diet induced hepatic inflammation and alters lipid metabolism in rats sharing similarity with human DIOS.

Fujiwara S, Izawa T, Mori M, Atarashi M, Yamate J, Kuwamura M Sci Rep. 2022; 12(1):21414.

PMID: 36496443 PMC: 9741655. DOI: 10.1038/s41598-022-25838-3.

High-fat diet combined with dextran sulfate sodium failed to induce a more serious NASH phenotype than high-fat diet alone.

Zhou Y, Feng Y, Yang L, Zheng P, Hang L, Jiang F Front Pharmacol. 2022; 13:1022172.

PMID: 36238563 PMC: 9551200. DOI: 10.3389/fphar.2022.1022172.

References

Tessitore A, Mastroiaco V, Vetuschi A, Sferra R, Pompili S, Cicciarelli G . Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model. Oncotarget. 2017; 8(32):53482-53494. PMC: 5581124. DOI: 10.18632/oncotarget.18585. View

Axling U, Olsson C, Xu J, Fernandez C, Larsson S, Strom K . Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab (Lond). 2012; 9(1):105. PMC: 3538623. DOI: 10.1186/1743-7075-9-105. View

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A . HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 2003; 38(3):335-42. DOI: 10.1016/s0168-8278(02)00415-4. View

Izawa T, Murakami H, Wijesundera K, Golbar H, Kuwamura M, Yamate J . Inflammatory regulation of iron metabolism during thioacetamide-induced acute liver injury in rats. Exp Toxicol Pathol. 2013; 66(2-3):155-62. DOI: 10.1016/j.etp.2013.12.002. View

Pietrangelo A . Mechanisms of iron hepatotoxicity. J Hepatol. 2016; 65(1):226-227. DOI: 10.1016/j.jhep.2016.01.037. View

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff P . Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis. Gastroenterology. 2007; 134(1):102-10. DOI: 10.1053/j.gastro.2007.10.038. View

Tung B, Emond M, Bronner M, Raaka S, Cotler S, Kowdley K . Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology. 2003; 124(2):318-26. DOI: 10.1053/gast.2003.50046. View

Guyader D, Thirouard A, Erdtmann L, Rakba N, Jacquelinet S, Danielou H . Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2006; 46(4):587-95. DOI: 10.1016/j.jhep.2006.09.021. View

Munoz M, Garcia-Erce J, Remacha A . Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2010; 64(4):281-6. DOI: 10.1136/jcp.2010.079046. View

10.

Tian Y, Wang H, Yuan F, Li N, Huang Q, He L . Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis. Biomed Res Int. 2016; 2016:9462571. PMC: 4804047. DOI: 10.1155/2016/9462571. View

11.

Tsukamoto H . Iron regulation of hepatic macrophage TNFalpha expression. Free Radic Biol Med. 2002; 32(4):309-13. DOI: 10.1016/s0891-5849(01)00772-9. View

12.

Nelson J, Wilson L, Brunt E, Yeh M, Kleiner D, Unalp-Arida A . Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology. 2011; 53(2):448-57. PMC: 3058264. DOI: 10.1002/hep.24038. View

13.

Sanduzzi Zamparelli M, Compare D, Coccoli P, Rocco A, Nardone O, Marrone G . The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Int J Mol Sci. 2016; 17(8). PMC: 5000623. DOI: 10.3390/ijms17081225. View

14.

Younossi Z, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H . Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9(6):524-530.e1. DOI: 10.1016/j.cgh.2011.03.020. View

15.

Xiong S, She H, Sung C, Tsukamoto H . Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol. 2003; 30(2):107-13. DOI: 10.1016/s0741-8329(03)00100-9. View

16.

Hofmeister A, Berger S, Buckel W . The iron-sulfur-cluster-containing L-serine dehydratase from Peptostreptococcus asaccharolyticus. Stereochemistry of the deamination of L-threonine. Eur J Biochem. 1992; 205(2):743-9. DOI: 10.1111/j.1432-1033.1992.tb16838.x. View

17.

Maliken B, Nelson J, Klintworth H, Beauchamp M, Yeh M, Kowdley K . Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease. Hepatology. 2013; 57(5):1806-13. PMC: 3637923. DOI: 10.1002/hep.26238. View

18.

Nelson J, Klintworth H, Kowdley K . Iron metabolism in Nonalcoholic Fatty Liver Disease. Curr Gastroenterol Rep. 2011; 14(1):8-16. DOI: 10.1007/s11894-011-0234-4. View

19.

Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C . Distinctly altered gut microbiota in the progression of liver disease. Oncotarget. 2016; 7(15):19355-66. PMC: 4991388. DOI: 10.18632/oncotarget.8466. View

20.

Zhu L, Baker S, Gill C, Liu W, Alkhouri R, Baker R . Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2012; 57(2):601-9. DOI: 10.1002/hep.26093. View